Compound florfenicol powder for animals and preparation thereof

Abstract

The invention discloses a veterinary compound florfenicol powder and a preparation method thereof, which aims at providing the veterinary compound florfenicol powder that has rapid onset of action for the treatment for porcine infectious pleuropneumonia and mycoplasmal pneumonia and can treat both manifestation and root causes of the diseases, alleviate the stress reactions when having the attacks of diseases of the pigs and improve the weight gain rate, and the preparation method that has simple process and easy realization. The powder is composed of the components with the following weight percentages: 5 to 20 percent florfenicol, 0.5 to 5 percent doxophylline and the rest of starch. The powder of the invention is a compound preparation which combines anti-bacterial drugs and the drugs for relieving cough and asthma, the florfenicol and the doxophylline are combined for usage, thus having rapid onset of action for the treatment for infectious pleuropneumonia and mycoplasmal pneumonia, effectivity and high efficiency; furthermore, the power can ease the stress reactions of the affected animals, significantly ease the clinical symptoms caused by the infectious pleuropneumonia and the mycoplasmal pneumonia, treat both manifestation and root causes of diseases, reduce the suffering of the affected pigs and increase the weight of the pigs.

Description

technical field [0001] The invention relates to a veterinary compound florfenicol powder and a preparation method thereof. Background technique [0002] Porcine infectious pleuropneumonia and mycoplasma pneumonia are common diseases in pigs, and porcine infectious pleuropneumonia can cause swine pneumonia and pleurisy. Mycoplasma pneumonia manifests as clinical symptoms such as cough, wheezing, dyspnea, and confluent bronchitis. Porcine infectious pleuropneumonia can cause pig death, and mycoplasma pneumonia can seriously affect pig growth. These two diseases are common pig respiratory system infectious diseases, which bring great losses to the pig industry. [0003] At present, because florfenicol can kill pathogens in a targeted manner, florfenicol alone is often used in the treatment of porcine infectious pleuropneumonia, but florfenicol has no control effect on clinical symptoms, such as coughing and wheezing. Therefore, The effect of treatment is slow, affecting the ...

AI Technical Summary

Problems solved by technology

These two diseases are common porcine respiratory infectious diseases, which bring great losses to the pig industry

[0003] At present, because florfenicol can kill pathogens in a targeted manner, florfenicol alone is often used in the treatment of porcine infectious pleuropneumonia, but florfenicol has no control effect on clinical symptoms, such as coughing and wheezing. Therefore, Slow response to treatment, affecting pig growth and gain rate

And doxofylline can specifically treat the clinical symptoms caused by the disease, such as cough, asthma, etc. Therefore, mycoplasma pneumonia is often treated with doxofylline, but doxofylline has no direct effect on the pathogen, and it can treat the symptoms but not the root cause. The therapeutic effect cannot be achieved, and the rebound rate is very high

And the combination of the two, taking the compound treatment of florfenicol powder and doxofylline powder, it is inconvenient for farmers to use, and it is prone to the phenomenon of drug waste caused by insufficient or excessive dosage of certain medicines, and it is uneconomical for users to use

At the same time, for farmers, it is difficult to clearly distinguish whether it is porcine infectious pleuropneumonia or mycoplasma pneumonia, and it is impossible to prescribe the right medicine, which brings difficulties to the treatment of the disease, and sometimes even delays the best treatment time